Top Biomanufacturing Companies in Europe

Friday, October 09, 2026

Medical device sponsors can lose months before a study even begins when protocol design and country requirements sit apart from site readiness and follow-up planning. A CRO may look capable on paper, yet still create friction if its regulatory approach does not reflect how individual European countries handle submissions and site activation. The real procurement question is therefore not how many services a provider offers, but whether it can connect study design to country-level execution without adding handoffs that delay enrollment or trigger late protocol changes. Just as important is knowing who owns each step once the study moves from planning into active management. Medic

Tuesday, October 06, 2026

Clinical research organisations are placing greater emphasis on improving trial execution as sponsors manage increasingly detailed study requirements and complex operational processes. CRO solutions can help strengthen coordination between research teams, study sites and sponsors while supporting smoother trial administration and more consistent oversight. In Europe, these services can contribute to better-organised clinical programs by helping research stakeholders manage specialised activities, maintain study quality and respond efficiently to operational demands.  Evolving Market Dynamics in CRO Solutions&

Tuesday, September 29, 2026

Expanding production capacity is not always a matter of adding equipment. For companies involved in xenogenic biomaterial design and manufacturing across Europe, growth plans may be influenced by a less visible factor: access to specialized expertise. The sector operates at the intersection of biological science, manufacturing processes and quality oversight. That combination creates workforce requirements that can be difficult to satisfy, particularly as organizations expand development activities or move toward larger-scale production. Finding the right talent can be particularly difficult in specialized fields such as biomaterials. Companies often look for professio

Monday, August 17, 2026

Advancements in drug development are encouraging pharmaceutical organisations in Europe to strengthen their focus on research-driven therapeutic approaches and specialised treatment platforms. Clinical stage pharmaceutical and therapeutics develops solutions that aid in the progression of promising drug candidates through key development phases while solving complex medical needs across targeted therapeutic areas. Such firms are strengthening the clinical research field, increasing therapy evaluation procedures and also helping enhance the establishment of targeted treatments to ensure much more deliverable specific health care. Growing collaboration between biotechnology firms,

Tuesday, August 11, 2026

An unexplained death investigation often starts with very little to go on. There may be no clear medical cause, limited information from the scene, no reliable witness account and no obvious physical explanation. That can leave the coroner or pathologist with a difficult question: did a substance play a role, or can toxicology help rule it out? Choosing a laboratory service therefore involves more than selecting a testing panel. The service needs to work effectively when important details are missing, without allowing that uncertainty to result in delays or inconclusive interpretation. Drug-related deaths are also becoming more difficult to investigate. Routine screening remains

Monday, August 03, 2026

Cell and gene therapy has become one of the most influential areas in modern medicine. Unlike conventional treatments that primarily manage symptoms, these therapies aim to address the biological causes of disease. Their potential to deliver long-lasting and, in some cases, curative outcomes has shifted the conversation from scientific possibility to clinical reality. Healthcare organizations, investors and policymakers now view the category as an important part of the future treatment landscape. Cell therapy is a form of medical treatment that uses cells for regeneration, replacement or enhancement of biological functions. Gene therapy involves introducing, manipulating or repl